Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2010
04/01/2010US20100080805 Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
04/01/2010US20100080804 Methods of treating inflammatory disorders of the lungs
04/01/2010US20100080802 Anti-il-tif antibodies and methods of use
04/01/2010US20100080801 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases
04/01/2010US20100080800 Humanized antibody
04/01/2010US20100080799 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
04/01/2010US20100080798 Kim-1 antagonists and use to modulate immune system
04/01/2010US20100080796 Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
04/01/2010US20100080794 Mutant polypeptide having effector function
04/01/2010US20100080793 DcR3 polypeptide, A TNFR homolog
04/01/2010US20100080792 Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen
04/01/2010US20100080769 Treatment of Chronic Lymphocytic Leukemia using Anti-CD20 Antibodies
04/01/2010DE102008049601A1 Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay Antibodies for determination of prothrombin fragment F2 / F1 + 2 in a homogeneous immunoassay
04/01/2010DE102008032236A1 Isolierung und/oder Identifizierung von Stammzellen mit adipozytärem, chondrozytärem und pankreatischem Differenzierungspotential Isolation and / or identification of stem cells with adipozytärem, chondrozytärem and pancreatic differentiation potential
04/01/2010CA2763039A1 Improved antibody molecules
04/01/2010CA2738598A1 Composition for treating disease
04/01/2010CA2738485A1 Frizzled-binding agents and uses thereof
04/01/2010CA2738427A1 A method of detecting antibodies and antibody-hiv virion complexes
04/01/2010CA2738252A1 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
04/01/2010CA2738209A1 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
04/01/2010CA2738032A1 Novel antibodies recognizing native annexin a3
04/01/2010CA2738027A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
04/01/2010CA2737795A1 Nitrogen responsive early nodulin gene
04/01/2010CA2737636A1 Antibodies against human il17 and uses thereof
04/01/2010CA2737580A1 High titer antibody production
04/01/2010CA2737351A1 Single chain antibody library design
04/01/2010CA2737241A1 Biological products
04/01/2010CA2736408A1 Bispecific anti-egfr/anti-igf-1r antibodies
03/2010
03/31/2010EP2169404A1 Method for measuring bonding activity of antibody which mimics antibody-dependent cell-mediated cytotoxic activity
03/31/2010EP2169076A2 Enzymes having alpha amylase activity and methods of use thereof
03/31/2010EP2169060A1 Novel polypeptide useful for diagnosis and treatment of cancer
03/31/2010EP2168987A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
03/31/2010EP2168986A2 CDR-repaired antibodies
03/31/2010EP2168985A1 Antibodies for determining the prothrombin fragment F2/F1+2 in a homogenous immunoassay
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168981A2 A Fibrin/Fibrinogen-binding conjugate
03/31/2010EP2167669A2 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
03/31/2010EP2167544A2 Monoclonal antibody directed against the human ldl receptor
03/31/2010EP2167543A1 Antigen binding proteins that bind par-2
03/31/2010EP2167542A1 Neutralizing monoclonal antibody against human dll4
03/31/2010EP2167541A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases
03/31/2010EP2167540A1 Heavy chain mutant leading to improved immunoglobulin production
03/31/2010EP2167534A2 Bioactive peptides and method of using same
03/31/2010EP2167531A2 Streptococcus pneumoniae pilus antigens
03/31/2010EP2167128A2 Engineered anti-alpha v- integrin hybrid antibodies
03/31/2010EP2167127A1 Novel formulation
03/31/2010EP2167125A1 An antibody specific for the tn antigen for the treatment of cancer
03/31/2010EP2167101A2 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis
03/31/2010EP2166844A1 Reduced-mass, long-acting dosage forms
03/31/2010EP1536820B1 Cancer therapy using whole glucan particles and antibodies
03/31/2010EP1194168B1 Methods and products for manipulating uncoupling protein expression
03/31/2010CN101688867A methods and biomarkers for diagnosing and monitoring psychotic disorders
03/31/2010CN101688204A Method for manufacturing a recombinant polyclonal protein
03/31/2010CN101688200A Sequence based engineering and optimization of single chain antibodies
03/31/2010CN101688183A Cancerous disease modifying antibodies
03/31/2010CN101688180A carbon and nitrogen-regulating gene and protein and modulation thereof
03/31/2010CN101688179A Recombinant protein production in avian ebx r cells
03/31/2010CN101687933A Immunoglobulin fusion proteins
03/31/2010CN101687932A Binding members for ige molecules
03/31/2010CN101687931A an anti-cancer cytotoxic monoclonal antibody
03/31/2010CN101687930A Chimeric and humanized anti-CD44 antibodies that mediate cancer cell cytotoxicity
03/31/2010CN101687929A Monoclonal antibodies against claudin-18 for treatment of cancer
03/31/2010CN101687928A Induction of tolerogenic phenotype in mature dendritic cells
03/31/2010CN101687927A antibody directed to g protein coupled receptors (gpcr)
03/31/2010CN101687926A neutralizing antibodies
03/31/2010CN101687925A engineered anti-il-23p19 antibodies
03/31/2010CN101687924A anti-muc17 antibody
03/31/2010CN101687923A The ed-a antigen of fibrinogen associated with the neovasculature of tumour metastases
03/31/2010CN101687922A methods of treating ophthalmic diseases
03/31/2010CN101687921A H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
03/31/2010CN101687920A Heavy chain mutant leading to improved immunoglobulin production
03/31/2010CN101687919A Methods of treating RSV infections and related conditions
03/31/2010CN101687918A Methods and compositions for the treatment of proliferative diseases
03/31/2010CN101687917A Coupling of antibody polypeptides at the c-terminus
03/31/2010CN101687916A Inflammation treatment, detection and monitoring via trem-1
03/31/2010CN101687915A Cross-species-specific cd3-epsilon binding domain
03/31/2010CN101687908A Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
03/31/2010CN101687039A Engineered anti-alpha v- integrin hybrid antibodies
03/31/2010CN101687038A Novel formulation
03/31/2010CN101687035A Novel compounds
03/31/2010CN101687031A Compositions and methods for treating ocular diseases and conditions
03/31/2010CN101687021A uses of monoclonal antibody 8h9
03/31/2010CN101687008A Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
03/31/2010CN101687005A Methods for treating cancer using agents that inhibit wnt16 signaling
03/31/2010CN101684470A Novel phospholipases and uses thereof
03/31/2010CN101684454A Method for preparing and separating definitive endoderm
03/31/2010CN101684158A Binding domain-immunoglobulin fusion proteins
03/31/2010CN101684157A anti-ox40l antibodies
03/31/2010CN101684156A Human TNF alpha monoclonal antibody, PEGylation nanoparticle and application thereof
03/31/2010CN101684155A Nucleotide and protein sequences of nogo genes and methods based thereon
03/31/2010CN101684154A Method for designing protein medicaments aiming at structural information of antigen epitope-antibody variable region
03/31/2010CN101684153A MAWBP antigen polypeptide, use of antoantibody in preparation of tumor detecting agent and detecting agent containing polypeptide
03/31/2010CN101684152A MFAP3L antigen polypeptide, use of antoantibody in preparation of tumor detecting agent and detecting agent containing polypeptide
03/31/2010CN101684148A Novel surface protein of neisseria meningitidis
03/31/2010CN101684147A moraxella catarrhalis proteins
03/31/2010CN101684146A Novel hcv non-structural polypeptide
03/31/2010CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
03/31/2010CN101683520A Methods for treating tweak-related conditions
03/30/2010US7687608 Methods for reducing the mitogenicity of lectin compositions
03/30/2010US7687607 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
1 ... 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 ... 1494